Related Experiment Video
Updated: Mar 12, 2026
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Long-term pediatric heart transplantation
Dimpna C Albert-Brotons1, Mohammad AlHaddad1, Mansour Alyami1
1Heart Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Insights
Pediatric heart transplantation offers good short-term survival but faces long-term challenges like cardiac allograft vasculopathy. Optimizing care requires a multidisciplinary approach, focusing on adherence and the transition to adult care for better graft survival.
Area of Science:
- Pediatric Cardiology
- Transplantation Immunology
- Immunosuppression Therapy
Background:
- Pediatric heart transplantation is the primary treatment for end-stage heart failure in children.
- Excellent short-term survival rates have been achieved, but long-term outcomes present significant challenges.
- Cardiac allograft vasculopathy (CAV) is the leading cause of late graft failure and mortality post-transplant.
Purpose of the Study:
- To explore chronic post-transplant complications in pediatric heart recipients.
- To identify factors influencing long-term graft survival and patient morbidity.
- To emphasize strategies for improving long-term outcomes in this population.
Main Methods:
- Review of literature on chronic post-transplant complications.
- Analysis of factors contributing to late graft failure and mortality.
- Discussion of management strategies for long-term care.
Main Results:
- Cardiac allograft vasculopathy (CAV), chronic rejection, renal dysfunction, and post-transplant lymphoproliferative disorders are major contributors to late morbidity and mortality.
- Adolescents exhibit a higher risk of graft loss, primarily due to nonadherence during the transition to adult care.
- Favorable growth, neurodevelopment, and quality of life are observed, particularly in younger recipients.
Conclusions:
- A multidisciplinary approach is crucial for optimizing long-term outcomes in pediatric heart transplantation.
- Key strategies include managing the transition to adult care, individualized immunosuppression, adherence support, and early detection of CAV.
- Re-transplantation is an option but associated with inferior outcomes compared to primary transplantation.
Abstract:
Pediatric heart transplantation remains the definitive therapy for selected children with end-stage heart failure. Short-term outcomes over the last decades have shown excellent survival; however, long-term outcomes remain a challenge. Cardiac allograft vasculopathy is the leading cause of late graft failure and mortality beyond the first year post-transplant. Chronic rejection, renal dysfunction related to lifelong immunosuppression, and post-transplant lymphoproliferative disorders are major contributors to late morbidity. Adolescents face an increased risk of graft loss, largely driven by nonadherence, which is most frequent during the transition to adult care. Growth, neurodevelopment, and quality of life are generally favorable, especially in children who undergo transplantation at younger ages. Re-transplantation is an option when graft dysfunction, but it is associated with inferior outcomes compared with primary transplant. This article explores detailed chronic post-transplant complications, including rejection, cardiac allograft vasculopathy (CAV), graft failure, infection, renal dysfunction, and malignancy, which influence long-term results. We highlight that a multidisciplinary approach with a special focus on the transition from pediatric to adult care, individualized immunosuppression, adherence support, cardiac rehabilitation, and early detection of graft vasculopathy is essential to further optimize long-term outcomes.
